BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2801513)

  • 1. Dissolution of crystalline gallium arsenide in aqueous solutions containing complexing agents.
    Pierson B; Van Wagenenn S; Nebesny KW; Fernando Q; Scott N; Carter DE
    Am Ind Hyg Assoc J; 1989 Sep; 50(9):455-9. PubMed ID: 2801513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gallium arsenide (GaAs) leaching behavior and surface chemistry changes in response to pH and O
    Ramos-Ruiz A; Field JA; Sun W; Sierra-Alvarez R
    Waste Manag; 2018 Jul; 77():1-9. PubMed ID: 30008399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro solubility and in vivo toxicity of gallium arsenide.
    Webb DR; Sipes IG; Carter DE
    Toxicol Appl Pharmacol; 1984 Oct; 76(1):96-104. PubMed ID: 6484996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reaction of gallium arsenide with concentrated acids: formation of arsine.
    Scott N; Carter DE; Fernando Q
    Am Ind Hyg Assoc J; 1989 Jul; 50(7):379-81. PubMed ID: 2756869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and excretion of orally and intraperitoneally administered gallium arsenide in the hamster.
    Yamauchi H; Takahashi K; Yamamura Y
    Toxicology; 1986 Sep; 40(3):237-46. PubMed ID: 3750324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of the toxic effects of gallium arsenide, indium arsenide and arsenic trioxide following intratracheal instillations to the lung of Syrian golden hamsters.
    Tanaka A; Hirata M; Omura M; Zhao M; Makita Y; Yamazaki K; Inoue N; Gotoh K
    Fukuoka Igaku Zasshi; 2000 Jan; 91(1):21-33. PubMed ID: 10714013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pulmonary toxicity of gallium arsenide, gallium(III) oxide, or arsenic(III) oxide intratracheally instilled into rats.
    Webb DR; Wilson SE; Carter DE
    Toxicol Appl Pharmacol; 1986 Mar; 82(3):405-16. PubMed ID: 3952726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testicular toxicity evaluation of arsenic-containing binary compound semiconductors, gallium arsenide and indium arsenide, in hamsters.
    Omura M; Hirata M; Tanaka A; Zhao M; Makita Y; Inoue N; Gotoh K; Ishinishi N
    Toxicol Lett; 1996 Dec; 89(2):123-9. PubMed ID: 8960154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testicular toxicity of gallium arsenide, indium arsenide, and arsenic oxide in rats by repetitive intratracheal instillation.
    Omura M; Tanaka A; Hirata M; Zhao M; Makita Y; Inoue N; Gotoh K; Ishinishi N
    Fundam Appl Toxicol; 1996 Jul; 32(1):72-8. PubMed ID: 8812231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for arsenic as the immunosuppressive component of gallium arsenide.
    Burns LA; Sikorski EE; Saady JJ; Munson AE
    Toxicol Appl Pharmacol; 1991 Aug; 110(1):157-69. PubMed ID: 1651571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity of indium arsenide, gallium arsenide, and aluminium gallium arsenide.
    Tanaka A
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):405-11. PubMed ID: 15276420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity Assessment of Gallium- and Indium-Based Nanoparticles Toward Human Bronchial Epithelial Cells Using an Impedance-Based Real-Time Cell Analyzer.
    Nguyen CH; Zeng C; Boitano S; Field JA; Sierra-Alvarez R
    Int J Toxicol; 2020; 39(3):218-231. PubMed ID: 32228215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolism of inorganic arsenic oxides, gallium arsenide, and arsine: a toxicochemical review.
    Carter DE; Aposhian HV; Gandolfi AJ
    Toxicol Appl Pharmacol; 2003 Dec; 193(3):309-34. PubMed ID: 14678742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological monitoring of arsenic exposure of gallium arsenide- and inorganic arsenic-exposed workers by determination of inorganic arsenic and its metabolites in urine and hair.
    Yamauchi H; Takahashi K; Mashiko M; Yamamura Y
    Am Ind Hyg Assoc J; 1989 Nov; 50(11):606-12. PubMed ID: 2596400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of gallium arsenide-induced suppression of the antibody-forming cell response by vehicle supernatants. I. Pharmacokinetics after in vitro and in vivo exposure.
    Burns LA; Munson AE
    J Pharmacol Exp Ther; 1993 Apr; 265(1):144-9. PubMed ID: 8386233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary clearance and toxicity of respirable gallium arsenide particulates intratracheally instilled into rats.
    Webb DR; Wilson SE; Carter DE
    Am Ind Hyg Assoc J; 1987 Jul; 48(7):660-7. PubMed ID: 3618480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrodeposition of crystalline GaAs on liquid gallium electrodes in aqueous electrolytes.
    Fahrenkrug E; Gu J; Maldonado S
    J Am Chem Soc; 2013 Jan; 135(1):330-9. PubMed ID: 23265429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic in the sera of gallium arsenide-exposed mice inhibits bacterial growth and increases host resistance.
    Burns LA; McCay JA; Brown R; Munson AE
    J Pharmacol Exp Ther; 1993 May; 265(2):795-800. PubMed ID: 8496824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of gallium arsenide-induced suppression of the antibody-forming cell response by vehicle supernatants. II. Nature and identification of reversing factors.
    Burns LA; Munson AE
    J Pharmacol Exp Ther; 1993 Apr; 265(1):150-8. PubMed ID: 8474002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biofunctionalisation of gallium arsenide with neutravidin.
    Santos Gomes B; Morgan DJ; Langbein W; Borri P; Masia F
    J Colloid Interface Sci; 2022 Feb; 608(Pt 3):2399-2406. PubMed ID: 34794804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.